Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 25, 2000
Tracheal constrictor drive above the apneic threshold in anesthetized dogsJ A Silverman, L Z Sommer, A Robicsek, et al.
Cell|June 28, 1996
A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactorsB J Doranz, J Rucker, Y Yi, et al.
Expert Review of Neurotherapeutics|February 1, 2023
UK medical cannabis registry: assessment of clinical outcomes in patients with headache disordersMartha Nicholas, Simon Erridge, Lara Bapir, et al.
Multiple Sclerosis and Related Disorders|May 10, 2024
Clinical outcome analysis of patients with multiple sclerosis - Analysis from the UK Medical Cannabis RegistryMatthew Murphy, Varinder Kaur, Hanh Lan Bui, et al.
Neuropsychopharmacology Reports|December 7, 2023
An observational study of clinical outcome measures in patients treated with cannabis-based medicinal products on the UK Medical Cannabis RegistrySimon Erridge, Ophilia Leung, Carl Holvey, et al.
Addiction (Abingdon, England)|December 10, 2025
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trialJohn Marsden, Michael Kelleher, Fiona Dunbar, et al.
ACR Open Rheumatology|March 13, 2025
UK Medical Cannabis Registry: An Analysis of Outcomes of Medical Cannabis Therapy for Hypermobility-Associated Chronic PainMary Dickinson, Simon Erridge, John Warner-Levy, et al.
Neuropediatrics|December 20, 2022
Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy-Analysis from the UK Medical Cannabis RegistrySimon Erridge, Carl Holvey, Ross Coomber, et al.
Depression and Anxiety|July 7, 2020
Historic psychedelic drug trials and the treatment of anxiety disordersNeil M Weston, Damian Gibbs, Catherine I V Bird, et al.
European Journal of Immunology|May 29, 1998
ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strainsM Samson, A L Edinger, P Stordeur, et al.
Pageof 12